1-10 of 10
Young Joo Min
Close
Sort by
Journal Articles

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Clinical Trials & Observations
Je-Hwan Lee, Young-Don Joo, Hawk Kim, Sung Hwa Bae, Min Kyoung Kim, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Jung-Hee Lee, Jae-Hoo Park, Dae-Young Kim, Won-Sik Lee, Hun Mo Ryoo, Myung Soo Hyun, Hyo Jung Kim, Young Joo Min, Yae-Eun Jang, Kyoo-Hyung Lee, for the Cooperative Study Group A for Hematology
Journal: Blood
Blood (2011) 118 (14): 3832–3841.
https://doi.org/10.1182/blood-2011-06-361410
Published: 2011
Journal Articles

Induction Therapy with “3+7” Chemotherapy Plus ATRA Followed by Consolidations with Three Courses of Idarubicin Alone and Maintenance Therapy with ATRA in Newly Diagnosed Acute Promyelocytic Leukemia (APL) Has An Excellent Leukemia-Free Survival but Minimal Toxicity in Low and Intermediate Risk Groups.

Moon-Young Choi, Yeung-Chul Mun, Se Hoon Park, Eun Kyung Cho, Jae Hoon Lee, Deog Yeon Jo, Inho Kim, Soo-Mee Bang, Sung-Soo Yoon, Seonyang Park, Byoung Kook Kim, Hawk Kim, Young Joo Min, Jae Hoo Park, Jong Jin Seo, Hyung Nam Moon, Moon Hee Lee, Cheol Soo Kim, Won Sik Lee, Young Don Joo, So Young Chung, Doyeun Oh, Dae Young Zang, Kyung Hee Lee, Myung Soo Hyun, Hong Suk Song, Heung Sik Kim, Sung Hyun Kim, Hyuk Chan Kwon, Hyo Jin Kim, Kyung Tae Park, Jin Seok Ahn, Yeon Hee Park, Myung Ju Ahn, Sung Hwa Bae, Hun-Mo Ryoo, Jung-Hye Choi, Hwi-Joong Yoon, Seung-Hyun Nam, Bong-Seog Kim, Thad T. Ghim, Chu-Myong Seong
Journal: Blood
Blood (2009) 114 (22): 2072.
https://doi.org/10.1182/blood.V114.22.2072.2072
Published: 2009
Journal Articles

Final Report of “Korean Multicenter AML-2000 Trial”: Intention to Treat Analysis Based on Cytogenetics Risk

Yeung-Chul Mun, Jae Hoon Lee, Byoung Kook Kim, Seonyang Park, Sung-Soo Yoon, Soo-Mee Bang, Hyung Nam Moon, Deog-Yeon Jo, Chul Soo Kim, Doyeon Oh, Jae Hoo Park, Young-Don Joo, Dae Young Zang, Inho Kim, Eun Kyoung Cho, Se Hoon Park, Jung-Hye Choi, Jong Jin Seo, Young Joo Min, Hawk Kim, Moon Hee Lee, Won Sik Lee, So Young Chong, Myung Soo Hyun, Kyung Hee Lee, Hong Suk Song, Heung Sik Kim, Hyo Jin Kim, Hyuk Chan Kwon, Sung Hyun Kim, Myung Ju Ahn, Jin Seok Ahn, Yeon Hee Park, Kyung Tae Park, Hun-Mo Ryoo, Sung Hwa Bae, Hwi-Joong Yoon, Bong-Seog Kim, Seung-Hyun Nam, Thad. T Ghim, Chu-Myong Seong
Journal: Blood
Blood (2008) 112 (11): 2975.
https://doi.org/10.1182/blood.V112.11.2975.2975
Published: 2008
Journal Articles

Effects of Temperature on the Change of HSP and the Viability of Mobilized Hematopoietic Stem Cells.

Hawk Kim, MD, PhD, Young Joo Min, MD, PhD, Jin Ho Baek, MD, PhD, Su Jin Shin, MD, Eui-Kyu Noh, MS, Eun-Hee Lee, RN, Sang-Kyu Park, MD, PhD, Jung Lim Lee, MD, PhD, Jae-Hoo Park, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4044.
https://doi.org/10.1182/blood.V110.11.4044.4044
Published: 2007
Journal Articles

Clinical Significance of PML/RAR Isoform in Patients of Acute Promyelocytic Leukemia.

Ki-Hyang Kim, MD, Won-Sik Lee, M.D., Kyoo-Hyung Lee, M.D., Je-Hwan Lee, M.D., Seong-Jun Choi, M.D., Jung-Hee Lee, M.D., Jae-Hoo Park, M.D., Young-Joo Min, M.D., Hawk Kim, M.D., Sung-Hwa Bae, M.D., Hun-Mo Ryoo, M.D., Myung-Soo Hyun, M.D., Min-Kyung Kim, M.D., Dae-Young Zang, M.D., Hyo-Jung Kim, M.D., Jin-Seok Ahn, M.D., Chul-Won Jung, M.D., Kyeong-Won Lee, M.D., Jung-Lim Lee, M.D., Young-Don Joo, M.D.
Journal: Blood
Blood (2007) 110 (11): 4218.
https://doi.org/10.1182/blood.V110.11.4218.4218
Published: 2007
Journal Articles

Prevalence and Trend of Hematopoietic Stem Cell Transplantation for Adult Aplastic Anemia/Pure Red Cell Aplasia in Korea.

Hawk Kim, MD, PhD, Jin Ho Baek, MD, PhD, Su Jin Shin, MD, Young Joo Min, MD, PhD, Jae-Hoo Park, MD, PhD, Je-Hwan Lee, MD, PhD, Kyoo-Hyung Lee, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3757.
https://doi.org/10.1182/blood.V110.11.3757.3757
Published: 2007
Journal Articles

Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).

Je-Hwan Lee, MD, Young-Don Joo, MD, Jae-Hoo Park, MD, Hun Mo Ryoo, MD, Myung Soo Hyun, MD, Dae Young Zang, MD, Jin Seok Ahn, MD, Junglim Lee, MD, Kyeong Won Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun-Hee Kim, RN, Won-Sik Lee, MD, Young Joo Min, MD, Hawk Kim, MD, Sung-Hwa Bae, MD, Min Kyung Kim, MD, Hyo Jung Kim, MD, Kyoo-Hyung Lee, MD
Journal: Blood
Blood (2007) 110 (11): 1833.
https://doi.org/10.1182/blood.V110.11.1833.1833
Published: 2007
Journal Articles

Alemtuzumab Plus Cyclosporin A for Treatment of Patients with Bone Marrow Failure Syndrome.

Hawk Kim, MD, PhD, Young Joo Min Min, MD, PhD, Jin Ho Baek, MD, PhD, Su Jin Shin, MD, Eun-Hee Lee, Eui-Kyu Noh, Mee-Young Kim, Jae-Hoo Park, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3759.
https://doi.org/10.1182/blood.V110.11.3759.3759
Published: 2007
Journal Articles

Enhanced Bacteriocidal Function by WKYMVm in Patients with Acute Leukemia.

Hawk Kim, MD, Soojin Shin, MD, Jae-Hoo Park, MD, Eui-Kyu Noh, Young Joo Min, MD
Journal: Blood
Blood (2006) 108 (11): 3844.
https://doi.org/10.1182/blood.V108.11.3844.3844
Published: 2006
Journal Articles

Alemtuzumab-Cyclosporin A for Bone Marrow Failure Syndrome.

Hawk Kim, MD, Soojin Shin, MD, Jeo-Hoo Park, MD, Young Joo Min, MD
Journal: Blood
Blood (2006) 108 (11): 3766.
https://doi.org/10.1182/blood.V108.11.3766.3766
Published: 2006